CSCI(Delisted)
Cosciens BiopharmaยทNASDAQ
--
--(--)
CSCI Profile
Cosciens Biopharma Inc.
A specialty biopharmaceutical company that develops and commercializing a diversified portfolio of pharmaceutical and diagnostic products
c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7
--
Cosciens Biopharma Inc., was established on September 12, 1990 under the Canada Business Corporations Act and continues to be managed by it. Aeterna Zentaris is a specialty biopharmaceutical company that commercializes and develops therapeutic and diagnostic tests. The company's product line includes compounds in all stages from development to sale. The company's main business strategy is to make progress together with strategic partners, and its key product candidates on the product development line are mainly used in the fields of oncology and endocrinology. In addition, the company has continued to advance other clinical and preclinical procedures, some of which have been authorized by different government agencies. The company's vision is to become an integrated professional biopharmaceutical company.
